Skip to content

Monster Beverage MNST Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Other financials

Income statement

See full
Revenue$2.4B+26.9%
Gross profit$1.3B+23.4%
Operating income$730.0M+28.1%
Net income$569.5M+28.6%
EPS (diluted)$0.58+28.9%

Balance sheet

See full
Cash & equivalents$2.0B+7.2%
Total debt$260.6M+321%
Total equity$8.7B+33.9%
Total assets$10.8B+31.8%

Cash flow

See full
Operating cash flow$605.0M+19.2%
CapEx$20.6M-29.1%
Free cash flow$584.4M+22.1%

Valuation

See full
Market cap$93.72B+52.3%
P/E46.1×+5.4×
P/S10.7×+2.4×

Profitability

See full
Gross margin55.5%+0.8pp
Operating margin29.3%+3.0pp
Net margin23.1%+2.8pp
FCF margin23.6%-0.6pp

Returns & leverage

See full
Return on equity26.7%+6.7pp
Debt / equity0.0×
Current ratio3.3×-0.1×